Menin-Inhibitor Targeted Maintenance in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Syndax Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Status
- RECRUITING
- Phase
- PHASE3
Revumenib in Combination With 7+3 + Midostaurin in AML
- Status
- RECRUITING
- Phase
- PHASE1
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
- Status
- RECRUITING
- Phase
- PHASE1
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access Program for Revumenib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Radiolabeled Revumenib in Adults With Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
- Status
- TERMINATED
- Phase
- PHASE1